Cipher Pharmaceuticals Schedules Q3 2023 Earnings Release and Conference Call

About this update from Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals Schedules Q3 2023 Earnings Release and Conference Call /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; } li.prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p.prnews_p { font-size:0.62em; font-family:"Arial"; color:black; margin:0in; } .prngen2{ PADDING-RIGHT:0.17em; PADDING-LEFT:0.17em; BORDER-TOP:black 0pt; BORDER-RIGHT:black 0pt; BORDER-BOTTOM:black 0pt; BORDER-LEFT:black 0pt } .prnml4{ MARGIN-TOP:0em; MARGIN-RIGHT:0em; MARGIN-BOTTOM:0em; MARGIN-LEFT:0.33em !IMPORTANT } .prnbcc{ BORDER-COLLAPSE: COLLAPSE } Canada NewsWire MISSISSAUGA, ON , Oct. 27, 2023 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (" Cipher " or "the Company ") today announced that it will release its financial results for the third quarter of 2023 on Thursday, November 9, 2023 . The Company will also host a conference call on Friday, November 10, 2023 at 8:30am ET to discuss the results and corporate developments. CONFERENCE CALL DETAILS DATE: Friday, November 10, 2023 TIME: 8:30 a.m. ET DIAL-IN NUMBER: (416) 764-8650 or (888) 664-6383 CONFERENCE ID: 74393673 REPLAY DIAL-IN: (888) 390-0541 (playback 393673#) Expires November 17, 2023 WEBCAST: https://app.webinar.net/AMLJYMeYrlE About Cipher Pharmaceuticals Inc. Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada , the U.S., and South America . For more information, visit www.cipherpharma.com . SOURCE Cipher Pharmaceuticals Inc. View original content: http://www.newswire.ca/en/releases/archive/October2023/27/c2762.html

View stock analysis, news, and events for Cipher Pharmaceuticals Inc.